1) Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends Cancer Epidemiol Biomarkers Prev 26:444-457.
2) Liu B, Gao S, Li S. A comprehensive comparison of CT, MRI, positron emission tomography or positron emission tomography/CT, and diffusion weighted imaging- MRI for detecting the lymph nodes metastases in patients with cervical cancer: a meta-analysis based on 67 studies Gynecol Obstet Invest 2017;82(3):209-22.
3) Hu J, Zhang K, Yan Y, Zang Y, Wang Y, Xue F. Diagnostic accuracy of preoperative 18 F-FDG PET or PET/CT in detecting pelvic and para-aortic lymph node metastasis in patients with endometrial cancer: a systematic review and meta- analysis. Arch Gynecol Obstet 2019;1-1.
4) Ebina Y, Mikami M, Nagase S, Tabata T, Kaneuchi M, Tashiro H, Mandai M, Enomoto T, Kobayashi Y, Katabuchi H, Yaegashi N. Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer Int J Clin Oncol 2019;24(1):1-9.
5) Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S. Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 2018;16(2):170-99.
6) Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Fisher CM. Cervical cancer, Version 1.2020 featured updates to the NCCN guidelines. JNCCN J Natl Comprehensive Cancer Network 2020;18(6):660-6.
7) Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 1987;60(S8):2035-41.
8) Sakuragi N, Satoh C, Takeda N, Hareyama H, Takeda M, Yamamoto R, Fujimoto T, Oikawa M, Fujino T, Fujimoto S. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy Cancer: Interdisciplinary International Journal of the American Cancer Society. Cancer 1999;85(7):1547-54.
9) Cervical Cancer Guideline (Version 1.2019). NCCN Clinical Practice Guidelines in Oncology
10) Uterine Neoplasm Guideline (Version 2.2019). NCCN Clinical Practice Guidelines in Oncology
11) Niikura H, Tsuji K, Tokunaga H, Shimada M, Ishikawa M, Yaegashi N. Sentinel node navigation surgery in cervical and endometrial cancer: a review Jpn J Clin Oncol 2019;49(6):495-500.
12) Kadkhodayan S, Hasanzadeh M, Treglia G, Azad A, Yousefi Z, Zarifmahmoudi L, Sadeghi R. Sentinel node biopsy for lymph nodal staging of uterine cervix cancer: a systematic review and meta-analysis of the pertinent literature. Eur J Surg Oncol. 2015 Jan;41(1):1-20.
13) Ballester M, Dubernard G, Lécuru F, Heitz D, Mathevet P, Marret H, Querleu D, Golfier F, Leblanc E, Rouzier R, Daraï E. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 2011;12:469–76.
14) Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, Method M, Ade M, Ivanova A, Boggess JF. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 2017;18:384–92.
15) Niikura H, Okamoto S, Otsuki T, Yoshinaga K, Utsunomiya H, Nagase S, Takano T, Ito K, Watanabe M, Yaegashi N. Prospective study of sentinel lymph node biopsy without further pelvic lymphadenectomy in patients with sentinel lymph node– negative cervical cancer Int J Gynecol Cancer 2012;22(7):1244-50.
16) Niikura H, Toki A, Nagai T, Okamoto S, Shigeta S, Tokunaga H, Shimada M, Watanabe M, Yaegashi N. Prospective evaluation of sentinel node navigation surgery in Japanese patients with low-risk endometrial cancer-safety and occurrence of lymphedema Jpn J Clin Oncol. 2021 Apr 1;51(4):584-589.
17) Bats AS, Buénerd A, Querleu D, Leblanc E, Daraï E, Morice P, Marret H, Gillaizeau F, Mathevet P, Lécuru F; SENTICOL collaborative group. Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: prospective, multicenter study. Gynecol Oncol 2011;123:230–5.
18) Dessources K, Aviki E, Leitao MM Jr. Lower extremity lymphedema in patients with gynecologic malignancies Int J Gynecol Cancer. 2020 Feb;30(2):252-260.
19) Moon WJ, Baek JH, Jung SL, Kim DW, Kim EK, Kim JY, Kwak JY, Lee JH, Lee JH, Lee YH, Na DG. Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations Korean J Radiol 2011;12(1):1-4.
20) Loveless ME, Li X, Huamani J, Lyshchik A, Dawant B, Hallahan D, Gore JC, Yankeelov TE. A method for assessing the microvasculature in a murine tumor model using contrast-enhanced ultrasonography J Ultrasound Med 2008;27(12):1699- 709.
21) Rubaltelli L, Corradin S, Dorigo A, Tregnaghi A, Adami F, Rossi CR, Stramare R. Automated quantitative evaluation of lymph node perfusion on contrast-enhanced sonography. AJR Am J Roentgenol 2007;188(4):977-83.
22) Mori N, Mugikura S, Miyashita M, Kudo Y, Suzuki M, Li L, Mori Y, Takahashi S, Takase K. Perfusion contrast-enhanced ultrasound to predict early lymph-node metastasis in breast cancer Jpn J Radiol 2018;37(2):145-53.
23) Qian CN, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, Ditlev J, Tsarfaty I, Hudson E, Jackson DG, Petillo D, Chen J. Preparing the “soil”: the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells Cancer Res 2006;66(21):10365-76.
24) Herman PG, Kim CS, de Sousa MA, Mellins HZ. Microcirculation of the lymph node with metastases. Am J Pathol 1976;85(2):333.
25) Niikura H, Kaiho-Sakuma M, Tokunaga H, Toyoshima M, Utsunomiya H, Nagase S, Takano T, Watanabe M, Ito K, Yaegashi N. Tracer injection sites and combinations for sentinel lymph node detection in patients with endometrial cancer Gynecol Oncol 2013;131(2):299-303.
26) Steinkamp HJ, Cornehl M, Hosten N, Pegios W, Vogl T, Felix R. Cervical lymphadenopathy: ratio of long-to short-axis diameter as a predictor of malignancy Br J Radiol 1995;68(807):266-70.
27) Prativadi R, Dahiya N, Kamaya A, Bhatt S. Ultrasound characteristics of benign vs malignant cervical lymph nodes Semin Ultrasound CT MR 2017 Oct 1 (Vol. 38, No. 5, pp. 506-515).
28) Yu M, Liu Q, Song HP, Han ZH, Su HL, He GB, Zhou XD. Clinical application of contrast-enhanced ultrasonography in diagnosis of superficial lymphadenopathy J Ultrasound Med 2010;29(5):735-40.
29) Dudau C, Hameed S, Gibson D, Muthu S, Sandison A, Eckersley RJ, Clarke P, Cosgrove DO, Lim AK. Can contrast-enhanced ultrasound distinguish malignant from reactive lymph nodes in patients with head and neck cancers? Ultrasound Med Biol 2014;40(4):747-54.
30) Mori N, Mugikura S, Takahashi S, Ito K, Takasawa C, Li L, Miyashita M, Kasajima A, Mori Y, Ishida T, Kodama T. Quantitative analysis of contrast-enhanced ultrasound imaging in invasive breast cancer: a novel technique to obtain histopathologic information of microvessel density Ultrasound Med Biol 2017;43(3):607-14.
31) Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis Nat Methods 2012;9(7):671-5.
32) Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma N Engl J Med 1991;324(1):1-8.
33) De Jong JS, Van Diest PJ, A Baak PJ. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 2000;36(4):306-12.
34) Ying M, Ahuja A. Sonography of neck lymph nodes. Part I: normal lymph nodes Clin Radiol 2003;58(5):351-8.
35) Slaisova R, Benda K, Jarkovsky J, Petrasova H, Szturz P, Valek V. Contrast-enhanced ultrasonography compared to gray-scale and power doppler in the diagnosis of peripheral lymphadenopathy Eur J Radiol 2013;82(4):693-8.
36) Agliata GG. Valeri G, Argalia E, Tarabelli, and Giuseppetti GM. 'Role of Contrast- Enhanced Sonography in the Evaluation of Axillary Lymph Nodes in Breast Carcinoma: A Monocentric Study' J Ultrasound Med 2017;36: 505-11.
37) Ignee A, Jedrejczyk M, Schuessler G, Jakubowski W, Dietrich CF. Quantitative contrast enhanced ultrasound of the liver for time intensity curves—reliability and potential sources of errors. EurJ Radiol 2011;73(1):153-8.
38) Colturato LF, Signorini Filho RC, Fernandes R, Gebrim LH, Oliani AH. Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence. Int J Gynaecol Obstet 2016;133:69–75.
39) Cibula D, Abu-Rustum NR, Dusek L, Zikán M, Zaal A, Sevcik L, Kenter GG, Querleu D, Jach R, Bats AS, Dyduch G, Graf P, Klat J, Lacheta J, Meijer CJLM, Mery E, Verheijen R, Zweemer RP. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer Gynecol Oncol 2012;124:496–501.
40) Guani B, Dorez M, Magaud L, Buenerd A, Lecuru F, Mathevet P. Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial. Int J Gynecol Cancer. 2019;29:447–452.
41) Guani B, Balaya V, Magaud L, Lecuru F, Mathevet P. The Clinical Impact of Low- Volume Lymph Nodal Metastases in Early-Stage Cervical Cancer: The Senticol 1 and Senticol 2 Trials. Cancers (Basel) 2020;12:1061.
42) Balaya V, Guani B, Magaud L, Hélène BK, Ngo C, Mathevet P, Lecuru F, SENTICOL. Long-term oncological safety of sentinel lymph node biopsy in early- stage cervical cancer. JCO. 2020;38:6006–6006.
43) St Clair CM, Eriksson AG, Ducie JA, Jewell EL, Alektiar KM, Hensley ML, Soslow RA, Abu-Rustum NR, Leitao MM Jr. Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma Ann Surg Oncol 2016;23:1653–9.
44) Piedimonte S, Richer L, Souhami L, Arseneau J, Fu L, Gilbert L, Alfieri J, Jardon K, Zeng XZ. Clinical significance of isolated tumor cells and micrometastasis in low-grade, stage I endometrial cancer J Surg Oncol 2018;118:1194–8.
45) Wilke LG, Ballman KV, McCall LM, Giuliano AE, Whitworth PW, Blumencranz PW, Reintgen DS, Burak WE, Leitch AM, Hunt KK. Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010 Ann Surg Oncol. 2010 Aug;17(8):1989-94.
46) Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial Lancet Oncol. 2018 Oct;19(10):1385-1393.
47) Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial JAMA. 2017 Sep 12;318(10):918-926.
48) Diniz TP, Faloppa CC, Mantoan H, Gonçalves BT, Kumagai LY, Menezes ANO, Badiglian-Filho L, Guimaraes APG, da Costa AABA, De Brot L, Baiocchi G. Pathological factors associated with non-sentinel lymph node metastasis in early stage cervical cancer J Surg Oncol. 2021 Mar;123(4):1115-1120.
49) Kennard JA, Stephens AJ, Ahmad S, Zhu X, Singh C, McKenzie ND, Kendrick JE, Holloway RW. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis Gynecol Oncol. 2019 Jul;154(1):53-59.
50) Gillot L, Baudin L, Rouaud L, Kridelka F, Noël A. The pre-metastatic niche in lymph nodes: formation and characteristics Cell Mol Life Sci. 2021 Jul 9.
論文の公開元へ
